Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01969227 · ClinicalTrials.gov registry record · NA

The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures

A NA study of Mechanical Ventilation and Respiratory Depression, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
15
Enrollment target
2
Study locations

NCT01969227: Completed NA study of Mechanical Ventilation and Respiratory Depression, sponsored by Massachusetts General Hospital.

NCT01969227 is a NA study of Mechanical Ventilation and Respiratory Depression that has completed, run by Massachusetts General Hospital. The registered enrollment target is 15 participants, below the 596-participant average among 14 other Mechanical Ventilation trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01969227, a NA study of Mechanical Ventilation and Respiratory Depression, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
2
Study locations

Study Summary

Impairment of airway patency is a common cause of extubation failure and opioids and hypnotics can adversely affect airway patency. Ketamine, a noncompetitive antagonist of N-methyl-D-aspartate (NMDA), unlike other anesthetics activates respiratory effort and promotes bronchodilation. At subanesthetic plasma concentration, ketamine reduces both opioid and propofol requirements. The purpose of this pharmaco-physiological interaction trial is to evaluate the effects of ketamine on breathing and electroencephalography in mechanically ventilated patients.

Primary Outcome

Inspiratory airflow measured during spontaneous breathing trials without ventilator support using a calibrated pneumotachometer connected to the ventilatory circuit. Airflow signals were recorded along with airway and esophageal pressures and analyzed. Inspiratory airflow represents the rate of air entering the lungs during inspiration and is reported in liters per second (L/s). Higher values indicate greater inspiratory airflow during spontaneous breathing. Measurements were obtained during bri

Interventions

  • DRUG Subanesthetic ketamine

Study Locations (2)

Massachusetts

  • Massachusetts General Hospital - Boston
  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2014-01
Est. Completion 2022-12
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT01969227 record still lists

NCT01969227 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 596-participant average among 14 other Mechanical Ventilation trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Mechanical Ventilation appearing as the primary indexed condition, and to 1 intervention - of which Subanesthetic ketamine is the first listed.

NCT01969227 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01969227 about?

NCT01969227 is a clinical study titled "The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures". Impairment of airway patency is a common cause of extubation failure and opioids and hypnotics can adversely affect airway patency. Ketamine, a noncompetitive antagonist of N-methyl-D-aspartate (NMDA), unlike other anesthetics activates respiratory effort and promotes bronchodilation. At subanesthet...

What is the current status of trial NCT01969227?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2014-01. Estimated completion is 2022-12.

What conditions does trial NCT01969227 study?

This clinical trial studies the following conditions: Mechanical Ventilation, Respiratory Depression, Airway Patency.

What interventions are being tested in trial NCT01969227?

The interventions under investigation include: Subanesthetic ketamine (DRUG).

Who is sponsoring clinical trial NCT01969227?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01969227 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mechanical Ventilation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01969227's enrollment target sits among peer trials

15 15th of 14 the lowest of 14 other Mechanical Ventilation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mechanical Ventilation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01969227, the US trial registry maintained by the National Library of Medicine. NCT01969227 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.